Drug Type Fusion protein |
Synonyms- |
Target |
Mechanism CFH inhibitors(Complement factor H inhibitors), DAF inhibitors(Complement decay-accelerating factor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
C3 glomerulopathy | Preclinical | DE | 23 Feb 2024 |